Comments on the FDA workshop are an important part of FDA’s efforts to solicit input from stakeholders. To view the workshop segment on inclusion of people with disabilities (session 3B) that features ACL’s Alison Barkoff, start at the 3:14:40 mark of the Day 1 video (slides for session 3B begin at slide number 112). The workshop also included a session (3C) titled, Approaches to Support the Inclusion and Clinical Study Participation of Individuals with Mental Illness (slides for session 3C begin on slide 128 and the session begins at the 00:03:45 mark of the Day 2 video).
The information gathered during the FDA workshop, in addition to comments submitted by the public, will form the basis for a report that the FDA will submit to Congress.
Why You Should View the Video and Consider Commenting
Too often the exclusion of people with disabilities from clinical trials is based on stereotypes about or biases against disabled people or a failure to take into account the availability of accommodations that can facilitate participation. Your voice is important to this discussion and can impact clinical trial decision making in the future!
Note About Accommodations
Contact